TIGIT predominantly regulates the immune response via regulatory T cells.
about
TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation.Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets.New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016Tim-3 and its role in regulating anti-tumor immunity.Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunityInterruption of OX40L signaling prevents costimulation blockade-resistant allograft rejection.TIGIT and Helios Are Highly Expressed on CD4+ T Cells in Sézary Syndrome Patients.Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Reversing T-cell Dysfunction and Exhaustion in Cancer.Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.Immune checkpoints and their inhibition in cancer and infectious diseases.Co-stimulate or Co-inhibit Regulatory T Cells, Which Side to Go?Immune checkpoint inhibitors for cancer treatment.The paired receptors TIGIT and DNAM-1 as targets for therapeutic antibodies.T cell exhaustion: from pathophysiological basics to tumor immunotherapy.Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation.TIGIT signalling pathway negatively regulates CD4+ T-cell responses in systemic lupus erythematosus.Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis.Tregs: Where We Are and What Comes Next?TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling.Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.DOCK8 enforces immunological tolerance by promoting IL-2 signaling and immune synapse formation in Tregs.Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword.Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.T Cell Exhaustion Signatures Vary with Tumor Type and are Severe in Glioblastoma.Tim-3, Lag-3, and TIGIT.Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis.Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity.PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.When worlds collide: Th17 and Treg cells in cancer and autoimmunity.Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.Coming of Age: CD96 Emerges as Modulator of Immune Responses.
P2860
Q30399437-089CB954-9AA0-42E7-9F91-189A46F6161CQ33650505-B9A73D2C-C363-44E3-B5E9-5FB9902B6BE3Q33731047-798A66D4-A228-41BA-BC6F-1A49FF42F798Q33814908-0C443BE7-04D5-4AED-B7C8-A60DEFA11D6FQ33909020-D5F6ED6C-59C6-4827-9ABD-74346DE27259Q36128123-F9BE4CEC-8FD3-439C-A509-38C4EC39575BQ36978175-ADA9236A-9CD9-4958-A522-89F5E751AD71Q37677433-29A3965F-0F44-4E0F-A2AA-8EB22296DBD7Q37711827-977DD9C8-BF7A-4EBD-A7C1-E7A3F2DAD249Q38730989-8ACA4503-3C32-4BB4-B320-6D20C94A019DQ38809776-5F3ECD31-EA48-464B-BC8B-F4CA6CAB471BQ38837469-49BD3698-9420-4E4F-BCA8-8DA354895451Q38845026-72B68B8B-C44D-4B00-8B23-2431AB52A99EQ38897638-7E82216E-091D-4821-9E72-162621D11B6DQ38988058-E72CEB1B-1A4E-41DD-B98A-A016E795882BQ39062949-C6A78DD1-8917-4F94-9C5D-EFBAEBF505E2Q39078341-EC9CF1BB-7468-42D1-9266-87E5A4653D7DQ39160992-B66BAFF9-8F0C-471C-9950-8B9BDC79FCA1Q39454807-63B18443-69C5-4E39-9A97-221FCD3F64ADQ40370455-9CFF3824-E43B-4BEF-A423-539FB8D5ED10Q40583098-460C9428-4ED1-4394-BC86-23B669C83400Q44412481-AF639318-7613-4EAF-8D27-F17AAB5EB2BFQ47141380-204560BC-6700-450D-8652-7FB398CC2647Q47217185-2343B806-4D9C-48DE-84CB-2F758D930A3FQ47271511-8ECC4FA3-256D-4EF5-BFD3-8B22253E36D3Q47550223-2D6109D6-D93D-4777-9C04-BF43BFF9DCDFQ47863316-0FE8631F-E659-4160-8B18-22D9DF11DF1EQ48273861-E33262D1-2BD3-44C9-8188-372C7BAC9BD3Q49851572-0B5B4B4E-3A64-47E1-8ADE-F506BE8B633CQ50043938-DCBE623E-CF52-4B01-8EE5-8B97114A0887Q50125564-FFC3CB5B-DBAA-448A-8DCA-965CCA6F4F50Q50204340-2A446F67-326C-457D-8E1C-223927EF6536Q50545420-19EC8043-95B3-42A9-AD29-04626BFA141CQ52676482-94B6DA46-398C-4D1D-B6D8-907CCE4A800FQ52682430-DB0AB555-1575-4A22-B972-BBFC1240C862Q52689973-84370BA8-BE14-4992-90D7-55B48DF9C06DQ52718461-0DD731B1-3019-46AB-8935-898459603C18Q54212829-358147D3-4C54-4612-B503-B764469B32AEQ55001208-3027CB9A-B4DE-4508-9847-45E08F3F55B3Q55026846-04ADBCAF-7DA0-4609-BCDB-BE5A5166FAF6
P2860
TIGIT predominantly regulates the immune response via regulatory T cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
TIGIT predominantly regulates the immune response via regulatory T cells.
@ast
TIGIT predominantly regulates the immune response via regulatory T cells.
@en
type
label
TIGIT predominantly regulates the immune response via regulatory T cells.
@ast
TIGIT predominantly regulates the immune response via regulatory T cells.
@en
prefLabel
TIGIT predominantly regulates the immune response via regulatory T cells.
@ast
TIGIT predominantly regulates the immune response via regulatory T cells.
@en
P2093
P2860
P50
P356
P1476
TIGIT predominantly regulates the immune response via regulatory T cells
@en
P2093
Ana C Anderson
Dewar J Tan
Kaori Sakuishi
Sema Kurtulus
Shin-Foong Ngiow
Vijay K Kuchroo
P2860
P304
P356
10.1172/JCI81187
P407
P577
2015-09-28T00:00:00Z